Table 3.
Treatment adherence during follow‐up among those who completed treatment
| Total (n = 158) | SVR12 (n = 152) | No SVR12 (n = 6) | Fisher’s exact test P‐value | |
|---|---|---|---|---|
| Week 4 | ||||
| Good adherence | 123 (77.9%) | 119 (78.3%) | 4 (66.7%) | 0.62 |
| Suboptimal adherence | 35 (22.2%) | 33 (21.7%) | 2 (33.3%) | |
| Insufficient adherence | 0 (0%) | 0 (0%) | 0 (0%) | |
| Week 8 | ||||
| Good adherence | 123 (77.9%) | 119 (78.3%) | 4 (66.7%) | 0.62 |
| Suboptimal adherence | 35 (22.2%) | 33 (21.7%) | 2 (33.3%) | |
| Insufficient adherence | 0 (0%) | 0 (0%) | 0 (0%) | |
| Week 12 | ||||
| Good adherence | 125 (79.1%) | 121 (79.6%) | 4 (66.7%) | 0.61 |
| Suboptimal adherence | 33 (20.9%) | 31 (20.4%) | 2 (33.3%) | |
| Insufficient adherence | 0 (0%) | 0 (0%) | 0 (0%) | |
Good adherence was defined as a TEO score of 0, suboptimal adherence as a TEO of 1 or 2 and insufficient adherence as a TEO of 3 or more. SVR, sustained virological response; TEO, Test for Evaluating Observance.